Sarcopenia, Frailty Circle, and Treatment With SGLT2 Inhibitors

Journal of Diabetes Investigation - Australia
doi 10.1111/jdi.12966
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

SGLT2 Inhibitors

2020English

Epidemiology of Sarcopenia and Frailty

2017English

Prevalence of Frailty, Cognitive Impairment, and Sarcopenia in Outpatients With Cardiometabolic Disease in a Frailty Clinic

BMC Geriatrics
GerontologyGeriatrics
2018English

SGLT2 Inhibitors: Mind the Gap

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2016English

Nutritional Problematic Related to Frailty and Sarcopenia in Older

Nutricion Hospitalaria
MedicineNutritionDietetics
2019English

Healthy Ageing, Appetite, Frailty and Sarcopenia: A Brief Overview

European Journal of Integrative Medicine
Alternative MedicineComplementary
2019English

Effects of SGLT2 Inhibitors in the Treatment of a Population With Type 2 Diabetes Mellitus

Endocrine Abstracts
2016English

The Frailty Phenotype and Sarcopenia: Similar but Not the Same

Aging Medicine
AgingGerontologyGeriatrics
2019English

Body Mass Index and Body Composition in Institutionalized Older Adults With Malnutrition, Sarcopenia and Frailty

European Journal of Public Health
EnvironmentalPublic HealthOccupational Health
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy